Neurocognitive Assessment in Youth Initiating HAART
Public ClinicalTrials.gov record NCT00683579. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
ATN 071 is a prospective cohort study comparing neurocognitive functioning in four groups of youth, age 18-24: Two groups with CD4+ T cells above 350 cells/mm3 and HIV RNA \>1,000 copies/ml, one initiating HAART (Group 1) and the other not initiating treatment (Group 2); and two groups with CD4+ T cells \< 350 cells/mm3, one initiating treatment (Group 3) and the other not initiating treatment (Group 4). Groups 2 and 3 represent standard of care. Group 1 and a portion of group 2 will be co-enrolled in ATN 061 and will be randomly assigned to group by that protocol.
Study identification
- NCT ID
- NCT00683579
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 220 participants
Conditions and interventions
Conditions
Interventions
- Early Treatment with HAART Drug
- No treatment Other
- HAART Treatment - standard care Drug
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 24 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2007
- Primary completion
- May 31, 2013
- Completion
- May 31, 2013
- Last update posted
- Feb 27, 2017
2007 – 2013
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Hopsital of Los Angeles | Los Angeles | California | 90027 | — |
| University of Southern California - IMPAACT Site | Los Angeles | California | 90033 | — |
| University of California at San Francisco | San Francisco | California | 94118 | — |
| Children's Hospital of Denver - IMPAACT Site | Aurora | Colorado | 80045 | — |
| Childrens National Medical Center | Washington D.C. | District of Columbia | 20010 | — |
| Howard University - IMPAACT Site | Washington D.C. | District of Columbia | 20060 | — |
| Children's Diagnostic and Treatment Center | Fort Lauderdale | Florida | 33316 | — |
| University of Miami School of Medicine | Miami | Florida | 33101 | — |
| University of South Florida | Tampa | Florida | 33606 | — |
| Stroger Hospital of Cook County | Chicago | Illinois | 60612 | — |
| Childrens Memorial Hospital | Chicago | Illinois | 60614 | — |
| Tulane University Health Sciences Center | New Orleans | Louisiana | 70112 | — |
| University of Maryland | Baltimore | Maryland | 21201 | — |
| Johns Hopkins University - IMPAACT Site | Baltimore | Maryland | 21287 | — |
| Children's Hospital of Michigan - IMPAACT Site | Detroit | Michigan | 48201 | — |
| Mount Sinai Medical Center | Manhattan | New York | 10128 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Childrens Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| St. Jude Children's Research Center | Memphis | Tennessee | 38105 | — |
| St. Jude Children's Research Hospital - IMPAACT Site | Memphis | Tennessee | 38105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00683579, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 27, 2017 · Synced Sep 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00683579 live on ClinicalTrials.gov.